Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Publikováno v:
Value in Health. 21:S131
Publikováno v:
Value in Health. 18(7)
Autor:
AS Abourawash, zA Elshafei
Publikováno v:
Value in Health. 20:A440
Publikováno v:
Value in Health, 18(7), A580-A581. ELSEVIER SCIENCE INC
Objectives: During the years, acute bacterial skin and skin structure infections (ABSSSIs) have seen an increase in incidence in many parts of the western world. Additionally, the treatment of ABSSSIs, generally consisting of surgical debridement or
Autor:
Claudius Rudin, Chris Cooper, R Mujica Mota, Tristan Snowsill, Martin Hoyle, Irina A Tikhonova, Jo Varley-Campbell
Publikováno v:
Value in Health. 19:A731
Objectives To review the evidence, submitted to the National Institute of Health and Care Excellence (NICE) by Celgene, on the clinical and cost-effectiveness of azacitidine for the treatment of acute myeloid leukaemia in adults with >30% bone marrow
Publikováno v:
Value in Health. 6(6)
Publikováno v:
Value in Health. 4(6)
Publikováno v:
Value in Health. 16:A234
Publikováno v:
Value in Health. 15:A424
Autor:
L. Delgado-Ortega, C Alvarez Sanz, C. Mellström, J. L Lopez-Sendon, M. Heras Fortuny, Elisabet Nikolic, Lars Wallentin
Publikováno v:
Value in Health. 14:A372
ObjectivesPLATO was a multi centered, double blind, randomized study that included 18,624 ACS patients from 43 countries, comparing ticagrelor + aspirin versus clopidogrel + aspirin. The PLATO demonstrated that ticagrelor was superior on the primary